Inspira Technologies Oxy B H N Ltd Quick Ratio (IINN) starting from the fourth quarter 2025 to fourth quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Inspira Technologies Oxy B H N Ltd  (NASDAQ: IINN)

Inspira Technologies Oxy B H N Ltd's Quick Ratio

IINN's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Inspira Technologies Oxy B H N Ltd's Cash & cash equivalent grew by 201.79 % in the Q4 2025 sequentially, faster than Current Liabilities, this led to improvement in Inspira Technologies Oxy B H N Ltd's Quick Ratio to 3.44, Quick Ratio remained below Inspira Technologies Oxy B H N Ltd average.

Within Medical Equipment & Supplies industry 54 other companies have achieved higher Quick Ratio than Inspira Technologies Oxy B H N Ltd in fourth quarter 2025. While Quick Ratio total ranking has improved so far during the Q4 2025 to 979, from total ranking in the second quarter 2025 at 1303.

Explain Quick Ratio?
How much Cash & cash equivalents IINN´s has?
What are IINN´s Current Liabilities?




IINN Quick Ratio (Dec 31 2025)
Q4
(Jun 30 2025)
Q3
(Dec 31 2024)
Q2
0
Q1
0
Q4
Y / Y Current Liabilities Change -47.9 % -55.88 % 40.35 % 2161.74 % 6.11 %
Y / Y Cash & cash equivalent Change -41.12 % -63.21 % -21.03 % 73.86 % -60.86 %
Quick Ratio MRQ 3.44 1.43 3.01 1.71 3.05
IINN's Total Ranking # 979 # 1303 # # #
Seq. Current Liabilities Change 25.35 % -61.66 % 15.07 % -5.81 % 6.17 %
Seq. Cash & cash equivalent Change 201.79 % -81.8 % 102.11 % -46.97 % 88.56 %



Quick Ratio fourth quarter 2025 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 55
Healthcare Sector # 420
Overall Market # 979


Quick Ratio Statistics
High Average Low
165.33 14.58 1.01
(Dec 31 2020)   0




Financial Statements
Inspira Technologies Oxy B H N Ltd's Current Liabilities $ 2 Millions Visit IINN's Balance sheet
Inspira Technologies Oxy B H N Ltd's Cash & cash equivalent $ 6 Millions Visit IINN's Balance sheet
Source of IINN's Sales Visit IINN's Sales by Geography


Cumulative Inspira Technologies Oxy B H N Ltd's Quick Ratio

IINN's Quick Ratio for the trailling 12 Months

IINN Quick Ratio

(Dec 31 2025)
12 Months
(Jun 30 2025)
12 Months
(Dec 31 2024)
12 Months
0
12 Months
0
12 Months
Y / Y Current Liabilities TTM Growth 7.49 % 27.54 % 70.05 % 69.91 % 2.56 %
Y / Y Cash & cash equivalent TTM Growth -25.27 % -41.08 % -35.28 % -28.51 % -37.38 %
Quick Ratio TTM 2.45 2.48 2.4 2.85 3.53
Total Ranking TTM # 3960 # 3885 # # #
Seq. Current Liabilities TTM Growth -13.92 % -13.26 % 8.52 % 32.67 % 2.13 %
Seq. Cash & cash equivalent TTM Growth -14.7 % -10.7 % -8.35 % 7.06 % -32.75 %


On the trailing twelve months basis In spite of the year on year decrease in IINN's Current Liabilities to $1.86 millions, cumulative Quick Ratio to 2.45 below the IINN average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 212 other companies have achieved higher Quick Ratio than Inspira Technologies Oxy B H N Ltd. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2025 from 3885 to 3960.

Explain Quick Ratio?
How much Cash & cash equivalents IINN´s has?
What are IINN´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 213
Healthcare Sector # 983
Within the Market # 3960


trailing twelve months Quick Ratio Statistics
High Average Low
5.51 3.52 1.71
(Dec 31 2021)   (Dec 31 2024)




Companies with similar Quick Ratio in the quarter ending Dec 31 2025, within Medical Equipment & Supplies Industry Quick RatioDec 31 2025 MRQ Cash & cash equivalentDec 31 2025 MRQ Current Liabilities
Logicmark Inc  9.08 $ 15.368  Millions$ 1.692  Millions
Ceribell Inc   8.86 $ 159.261  Millions$ 17.984  Millions
Bluejay Diagnostics Inc  8.65 $ 5.165  Millions$ 0.597  Millions
Delcath Systems Inc   8.39 $ 91.036  Millions$ 10.849  Millions
Sight Sciences Inc   8.34 $ 91.965  Millions$ 11.027  Millions
Carlsmed Inc   7.69 $ 109.793  Millions$ 14.280  Millions
EBR Systems, Inc.  7.57 $ 101.595  Millions$ 13.422  Millions
Inmode Ltd   7.16 $ 555.244  Millions$ 77.569  Millions
Beta Bionics Inc   7.09 $ 219.125  Millions$ 30.924  Millions
Orchestra Biomed Holdings Inc   6.66 $ 106.512  Millions$ 15.985  Millions
Innovative Eyewear Inc   6.23 $ 6.511  Millions$ 1.045  Millions
Nutriband Inc   5.83 $ 4.575  Millions$ 0.784  Millions
Cvrx inc   5.69 $ 75.708  Millions$ 13.317  Millions
Transmedics Group Inc   5.47 $ 488.366  Millions$ 89.305  Millions
Autonomix Medical Inc   5.35 $ 9.136  Millions$ 1.707  Millions
Inspiremd Inc   5.06 $ 54.211  Millions$ 10.712  Millions
Perspective Therapeutics Inc   5.05 $ 144.737  Millions$ 28.679  Millions
Iradimed Corporation  5.03 $ 51.159  Millions$ 10.180  Millions
Collplant Biotechnologies Ltd  5.00 $ 5.950  Millions$ 1.191  Millions
Soleno Therapeutics Inc  4.98 $ 305.472  Millions$ 61.363  Millions
Heartflow Inc   4.85 $ 176.786  Millions$ 36.448  Millions
Sensus Healthcare Inc   4.68 $ 22.083  Millions$ 4.722  Millions
Orasure Technologies Inc  4.64 $ 199.278  Millions$ 42.947  Millions
Outset Medical Inc   4.49 $ 168.946  Millions$ 37.630  Millions
Irhythm Holdings Inc   4.46 $ 583.763  Millions$ 131.003  Millions
Omada Health Inc   4.38 $ 222.036  Millions$ 50.668  Millions
Procept Biorobotics Corporation  4.35 $ 286.503  Millions$ 65.795  Millions
Clearpoint Neuro Inc   4.27 $ 45.923  Millions$ 10.765  Millions
Nexalin Technology Inc   4.20 $ 3.723  Millions$ 0.887  Millions
Alpha Pro Tech Ltd   4.19 $ 16.988  Millions$ 4.058  Millions

Date modified: 2026-09-02T17:55:35+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.